Literature DB >> 14511232

Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells.

Dianne L Commeren1, Peter L Van Soest, Khalil Karimi, Bob Löwenberg, Jan J Cornelissen, Eric Braakman.   

Abstract

The immunoregulatory cytokine, interleukin-10 (IL-10), has been shown to inhibit the maturation of human myeloid dendritic cells (DC). In the present study, we demonstrate that IL-10 has paradoxical effects on the maturation of murine myeloid bone marrow-derived DC. On the one hand, IL-10 inhibits the maturation of murine myeloid DC. The addition of IL-10 to granulocyte-macrophage colony-stimulating factor (GM-CSF)-supported murine BM-derived DC cultures reduced the frequency of major histocompatibility complex (MHC) class IIbright cells. These IL-10-pretreated DC have a reduced capacity to stimulate T cells in an allogeneic mixed leucocyte reaction. On the other hand, however, and in contrast to the effects of IL-10 on human DC, we found that the addition of IL-10 from the initiation of the culture onwards induced an up-regulation of the expression of the costimulatory molecules CD40, CD80 and CD86 on murine myeloid DC, as compared to DC generated with GM-CSF only. Moreover, a subpopulation of IL-10-pretreated MHC class IIdim DC lacked the capacity to take up dextran-fluorescein isothiocyanate (FITC), a feature of DC maturation. Taken together, our data demonstrate that the generation of murine myeloid DC in the presence of IL-10 results in a population of incompletely matured MHC class IIdim CD80+ CD86+ DC. These DC lack T-cell stimulatory capacity, suggesting a role for IL-10 in conferring tolerogenic properties on murine myeloid DC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511232      PMCID: PMC1783045          DOI: 10.1046/j.1365-2567.2003.01730.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

Review 1.  T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.

Authors:  P Kaliński; C M Hilkens; E A Wierenga; M L Kapsenberg
Journal:  Immunol Today       Date:  1999-12

Review 2.  Potential of tolerogenic dendritic cells for transplantation.

Authors:  A E Morelli; H Hackstein; A W Thomson
Journal:  Semin Immunol       Date:  2001-10       Impact factor: 11.130

Review 3.  Dendritic cells as a tool to induce anergic and regulatory T cells.

Authors:  H Jonuleit; E Schmitt; K Steinbrink; A H Enk
Journal:  Trends Immunol       Date:  2001-07       Impact factor: 16.687

4.  Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells.

Authors:  M L Albert; M Jegathesan; R B Darnell
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

5.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

6.  Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo.

Authors:  M B Lutz; R M Suri; M Niimi; A L Ogilvie; N A Kukutsch; S Rössner; G Schuler; J M Austyn
Journal:  Eur J Immunol       Date:  2000-07       Impact factor: 5.532

7.  CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.

Authors:  Kerstin Steinbrink; Edith Graulich; Sebastian Kubsch; Jürgen Knop; Alexander H Enk
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

8.  Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells.

Authors:  K Steinbrink; H Jonuleit; G Müller; G Schuler; J Knop; A H Enk
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

9.  Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.

Authors:  M V Dhodapkar; R M Steinman; J Krasovsky; C Munz; N Bhardwaj
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

10.  Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity.

Authors:  Mauritius Menges; Susanne Rössner; Constanze Voigtländer; Heike Schindler; Nicole A Kukutsch; Christian Bogdan; Klaus Erb; Gerold Schuler; Manfred B Lutz
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  11 in total

1.  A role for anti-CD45RB monoclonal antibody treatment upon dendritic cells.

Authors:  Hui Qi; Jin-Peng Liu; Chun-Yan Deng; Han-Xin Zhou; Shao-Ping Deng; Fu-Rong Li
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Involvement of IL-10 in exhaustion of myeloid dendritic cells and rescue by CD40 stimulation.

Authors:  Kiichi Kajino; Ichiro Nakamura; Hiromichi Bamba; Toshihiro Sawai; Kazumasa Ogasawara
Journal:  Immunology       Date:  2006-10-11       Impact factor: 7.397

3.  Effect of immune tolerance induced by immature dendritic cells and CTLA4-Ig on systemic lupus erythematosus: An in vivo study.

Authors:  Cuili Huang; Lidan Zhang; Fang Ling; Sijian Wen; Yanyan Luo; Hui Liu; Jingping Liu; Wenjun Zheng; Ming Liang; Jian Sun; You-Kun Lin
Journal:  Exp Ther Med       Date:  2018-01-04       Impact factor: 2.447

Review 4.  Acquired resistance to cancer immunotherapy.

Authors:  Arianna Draghi; Christopher Aled Chamberlain; Andrew Furness; Marco Donia
Journal:  Semin Immunopathol       Date:  2018-07-02       Impact factor: 9.623

5.  Expression of CD11c+HLA-DR+dendritic cells and related cytokines in the follicular fluid might be related to pathogenesis of ovarian hyperstimulation syndrome.

Authors:  Sen-Lin Shi; Zhao-Feng Peng; Gui-Dong Yao; Hai-Xia Jin; Wen-Yan Song; Hong-Yi Yang; Ru-Yue Xue; Ying-Pu Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 6.  TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials.

Authors:  Khalil Choucair; Susan Morand; Laura Stanbery; Gerald Edelman; Lance Dworkin; John Nemunaitis
Journal:  Cancer Gene Ther       Date:  2020-04-28       Impact factor: 5.987

7.  Interleukin-10 reorganizes the cytoskeleton of mature dendritic cells leading to their impaired biophysical properties and motilities.

Authors:  Xiaoli Xu; Xianmei Liu; Jinhua Long; Zuquan Hu; Qinni Zheng; Chunlin Zhang; Long Li; Yun Wang; Yi Jia; Wei Qiu; Jing Zhou; Weijuan Yao; Zhu Zeng
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

8.  A Lactobacillus rhamnosus strain induces a heme oxygenase dependent increase in Foxp3+ regulatory T cells.

Authors:  Khalil Karimi; Nalaayini Kandiah; Jessie Chau; John Bienenstock; Paul Forsythe
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

9.  Global Inhibition of DC Priming Capacity in the Spleen of Self-Antigen Vaccinated Mice Requires IL-10.

Authors:  Douglas M Marvel; Olivera J Finn
Journal:  Front Immunol       Date:  2014-02-17       Impact factor: 7.561

10.  Lactobacillus rhamnosus GG Activation of Dendritic Cells and Neutrophils Depends on the Dose and Time of Exposure.

Authors:  Shirong Cai; Matheswaran Kandasamy; Juwita N Rahmat; Sin Mun Tham; Boon Huat Bay; Yuan Kun Lee; Ratha Mahendran
Journal:  J Immunol Res       Date:  2016-07-20       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.